| __timestamp | Geron Corporation | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 1153000 | 1288519000 |
| Thursday, January 1, 2015 | 36371000 | 1465761000 |
| Friday, January 1, 2016 | 6162000 | 1598800000 |
| Sunday, January 1, 2017 | 1065000 | 1725300000 |
| Monday, January 1, 2018 | 1066000 | 1627800000 |
| Tuesday, January 1, 2019 | 460000 | 1448800000 |
| Wednesday, January 1, 2020 | 253000 | 1483300000 |
| Friday, January 1, 2021 | 1393000 | 1685500000 |
| Saturday, January 1, 2022 | 596000 | 1936300000 |
| Sunday, January 1, 2023 | 237000 | 2327500000 |
Unlocking the unknown
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, United Therapeutics Corporation has consistently outperformed Geron Corporation, showcasing a robust revenue trajectory. From 2014 to 2023, United Therapeutics saw its revenue soar by approximately 80%, peaking at $2.33 billion in 2023. This growth reflects its strategic advancements and market adaptability.
Conversely, Geron Corporation's revenue journey tells a different story. Despite a notable spike in 2015, where revenue increased by over 3000% compared to the previous year, the company faced a downward trend, culminating in a modest $237,000 in 2023. This stark contrast highlights the challenges smaller biotech firms face in sustaining growth amidst industry giants.
These insights underscore the importance of innovation and strategic planning in the competitive biotech landscape.
Breaking Down Revenue Trends: Novo Nordisk A/S vs Geron Corporation
AbbVie Inc. vs Geron Corporation: Examining Key Revenue Metrics
Revenue Insights: Zoetis Inc. and United Therapeutics Corporation Performance Compared
Revenue Showdown: United Therapeutics Corporation vs Genmab A/S
Who Generates More Revenue? United Therapeutics Corporation or Exelixis, Inc.
Comparing Revenue Performance: United Therapeutics Corporation or Lantheus Holdings, Inc.?
United Therapeutics Corporation vs Cytokinetics, Incorporated: Examining Key Revenue Metrics
United Therapeutics Corporation and PTC Therapeutics, Inc.: A Comprehensive Revenue Analysis
United Therapeutics Corporation vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Breaking Down Revenue Trends: United Therapeutics Corporation vs Celldex Therapeutics, Inc.
Who Generates More Revenue? Bio-Techne Corporation or Geron Corporation
Comparing Revenue Performance: Corcept Therapeutics Incorporated or Geron Corporation?